Company profile
Home Page - Aptamer Group
Rapid Optimer development as antibody alternatives for therapeutic, drug delivery, diagnostics and bioprocessing.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
CH01 | Transaction MzQzOTUzMjQ1OWFkaXF6a2N4
Published 15 Oct 2024 09:28
AP01 | Transaction MzQzNjgwNTg5OGFkaXF6a2N4
Published 23 Sep 2024 08:37
SH01 | Transaction MzQzMzA3Nzg2MmFkaXF6a2N4
Published 22 Aug 2024 09:19
RESOLUTIONS | Transaction QUQ5S0E2WERhZGlxemtjeA | Paper/PDF filed
Published 22 Aug 2024 07:03
AP01 | Transaction MzQzMjE0OTUwN2FkaXF6a2N4
Published 14 Aug 2024 12:17
TM01 | Transaction MzQzMjE0ODk5NGFkaXF6a2N4
Published 14 Aug 2024 12:13
TM01 | Transaction MzQzMjE0ODkwNWFkaXF6a2N4
Published 14 Aug 2024 12:12
Company registered at Companies House
1 May 2023 to 30 Apr 2025
